![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Clarochem Ireland Ltd. Dublin 15 Ie, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Levodropropizine, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2012-083 - Rev 01
This Chemical Type CEP, issued on January 17, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1535 associated with this CEP further emphasizes